磁共振胰胆管水成像与内镜下逆行胰胆管造影术临床应用的对比研究

目的通过磁共振胰胆管水成像（MRCP）与内镜下逆行胰胆管造影术（ERCP）对胆胰疾病诊断的对比研究,为临床更好地选择诊治方案提供依据。方法回顾性分析120例行ERCP和（或）MRCP检查并经手术、病理等证实为胆胰疾病患者的临床资料。结果 MRCP和ERCP对胆道结石和胆管癌诊断的总符合率比较,无统计学差异（P均〉0.05）,对壶腹癌、慢性胰腺炎、胆囊切除术后胆汁漏或梗黄诊断符合率比较,差异均有统计学意义（P〈0.05）。ERCP有较好的治疗作用。结论 MRCP与ERCP各有优势,可以互相补充,根据胆胰疾病患者的临床表现、检查目的及治疗手段对两者的合理选择至关重要。     

磁共振胰胆管造影术对胰胆系疾病的诊断价值

目的通过磁共振胰胆管造影术(MRCP)与经内镜逆行胰胆管造影术(ERCP)的对照研究,评价MRCP对胰胆系疾病的诊断价值.方法40例疑有胰胆系疾病的患者在PhilipsGyroscanNT1.0T超导系统上作MRCP检查,ERCP采用常规方法检查.患者男24例,女16例,年龄34岁～68岁,平均56岁.28例先行MRCP后再作ERCP,12例先行ERCP,大部分患者两者间隔时间1d～2d,最长达7d.两者结果作对照研究.结果本组资料中,MRCP对胰胆系疾病总的诊断价值为敏感度89.1%、特异度100%、准确度90%,ERCP总的诊断价值为敏感度84.2%、特异度100%、准确度85%,两者统计学上无显著性差异(x2=0.11,P>0.05).结论MRCP具有无创伤性,与ERPC相比较,在诊断胰胆系疾病方面具有同等的价值,但没有治疗作用,目前尚难以取代ERCP.     

诊断性ERCP研究进展

内镜下逆行胰胆管造影术(ERCP)仍是目前诊断胰胆疾病的金标准.但ERCP术后胰腺炎不可避免.自从出现磁共振胰胆管造影(MRCP)以来,MRCP已被广泛应用于临床,具有代替诊断性ERCP的潜在可能性.但目前MRCP设备尚不普及.和ERCP相比,MRCP图象不十分理想.随着技术进步,诊断性ERCP应用有可能逐渐减少,成为取得组织学、细胞学标本和功能研究的方法.     

超声内镜诊断胆管恶性狭窄13例

目的:比较超声内镜(EUS)、内镜下逆行胰胆管造影术(ERCP)及磁共振胰胆管成像(MRCP)在诊断胆管恶性狭窄中的临床价值.方法:回顾性分析2008-01/2010-05天津市南开医院76例胆管恶性狭窄患者的EUS、ERCP、MRCP检查结果,比较敏感性、特异性、阳性预测值、阴性预测值及准确率.结果:EUS诊断胆管恶性狭窄敏感性(94.2%vs78.5%)、特异性(84.6%vs57.1%)、阳性预测值(89.1%vs64.5%)、阴性预测值(73.3%vs41.3%)、准确率(91.6%vs71.6%)均明显高于MRCP.EUS诊断胆管恶性狭窄敏感性(94.2%vs80.5%)、特异性(84.6%vs68.4%)、准确性(91.6%vs71.6%)明显优于ERCP.结论:EUS诊断胆管恶性狭窄,具有敏感性、特异性及准确性高的优势.     

ERCP与MRCP对胆胰疾病诊断的比较分析

在胰胆疾病的诊断中，影像学检查越来越起重要的作用。近年来，除了十二指肠逆行胰胆管造影(ERCP)，磁共振胰胆管造影(MRCP)作为胰胆系疾病的无创伤性诊断新技术，已被广泛应用于临床。早期研究显示，MRCP在胰胆管扩张方面有较高的准确性，但在胆总管结石与肿瘤的诊断方面尚有争论。本文就ERCP和MRCP对胆胰疾病的诊断价值做一比较分析。     

胆胰疾病磁共振误诊及与ERCP结果比较分析

磁共振胰胆管显影术（MRCP）作为一种无创性诊断技术，其临床应用日趋增多，而经内镜逆行胰胆管造影（ERCP）作为胆胰系疾病的诊断金标准已在临床应用多年。为了评价MRCP和ERCP对胆胰系疾病的诊断价值，我们分析了56例胆胰疾病病例磁共振胰胆管造影（MRCP）误诊情况及与ERCP结果进行比较，报道如下。     

ERCP联合胆汁肿瘤标志物测定对可疑胰胆管疾病的诊断价值研究

目的探讨胆汁肿瘤标志物测定在ERCP对可疑胰胆管疾病诊断中的辅助作用。方法对经B超、MRCP、生化、血清肿瘤标志物等常规检查未能明确诊断的可疑胰胆管疾病患者,进行ERCP检查或对症治疗,同时行胆汁肿瘤标志物测定,选取29例明确诊断的病例分为良性和恶性组,比较2组在生化、肿瘤标志物上的差别,同时评估和比较B超、EUS、MRCP、ERCP、ERCP＋胆汁肿瘤标志物对可疑胰胆管疾病的诊断价值。结果生化、血清癌胚抗原（CEA）、血清CA19-9、胆汁CA19—9,在2组间差异无统计学意义,而胆汁CEA在恶性组中平均值高于良性组,且差异有统计学意义（P〈0．001）,ERCP联合胆汁CEA测定对可疑胰胆管疾病诊断准确率为69．0％（20／29）,高于单纯的B超6．9％（2／29）、EUS60．0％（6／10）、MRCP37．9％（11／D）和ERCP41．4％（12／29）。结论ERCP联合胆汁的CEA测定能进一步提高可疑胰胆管疾病诊断的准确性,对良恶性疾病的鉴别诊断有着辅助作用。     

内镜逆行胰胆管造影术后并发症及其防治

内镜逆行胰胆管造影术（endoscopic retrograde cholangiopancreatography，ERCP）目前广泛应用于各种胰胆疾病的诊断和治疗。总体来讲，成功率较高，安全性较好，但术后并发症也同时成为临床工作中不可忽视的问题。此文就ERCP术后并发症及其防治现状作一综述。     

胰胆管镜在胆胰肿瘤诊断中的应用进展

临床上胆胰管狭窄和导管内病变的诊断主要是依靠间接影像学技术如磁共振胰胆管造影术（MRCP）、超声内镜检查术（EUS）、管腔内超声检查术（IDUS）和ERCP等,联合应用这些技术,30％的病变仍然不能明确诊断。ERCP联合常规组织活检技术包括管内细胞刷、管内组织活检和超声引导下细针穿刺术,诊断的敏感性仍低于70％。应用胰胆管镜（子母镜）可在直视下观察胆、胰病变,并取得组织病理;     

超声内镜在可疑胆胰疾病ERCP术前的初步应用

目的 超声内镜(EUS)在可疑胆胰病变患者行内镜逆行胰胆管造影(ERCP)术前的临床应用价值.方法 对15例急性胰腺炎、梗阻性黄疸、胆总管扩张或反复腹痛等病史的患者,经腹部B超、CT和/或MRCP检查可疑胆胰病变,术前行EUS检查诊断,并经ERCP确认.结果 15例患者确诊胆总管结石并行EST取石术9例,确诊壶腹部肿瘤2例,胆管内乳头状瘤2例,十二指肠乳头炎性狭窄1例,胰管结石1例.结论 EUS对可疑胆胰病变有很高的诊断价值,特别能提高胆总管结石确诊率,高于MRCP检查,并能指导ERCP,提高治疗效果,减少风险.     

Clinical efficacy of magnetic resonance cholangiopancreatography in the diagnosis of biliary tract diseases]

This study was carried out to clarify the efficacy of magnetic resonance cholangiopancreatography (MRCP) in the diagnosis of biliary tract diseases, Three hundred and eleven patients who underwent MRCP and ERCP during the period from January 1999 to December 1999 at our institution were included in the study. Two gastroenterologists who were blinded to results of direct cholangiography and final diagnoses interpreted MRCP images prospectively. The biliary duct was visualized by MRCP and ERCP in 99.4% and 89.5% of the cases, respectively. The sensitivity, specificity, and accuracy of MRCP in the diagnosis of choledocholithiasis were 95%, 97%, and 97%, respectively. MRCP depicted the presence of strictures with a sensitivity, specificity, and accuracy of 97%, 96%, and 96%, respectively. There were three false-positive cases because of artifacts from arterial compression, The accuracy of MRCP and ERCP in differentiation of benign strictures from malignant ones was 85% and 96%, respectively. Based on these results, it is concluded that MRCP has high capability in visualization of the biliary tree, and in detection of stones and strictures, To avoid over and under-diagnosis, awareness of some pitfalls inherent in, MRCP is important. We suggest that MRCP should be recommended for patients with suspicion of biliary tract diseases in the initial stage of making diagnosis.     

Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree.

BACKGROUND: Traditionally, ERCP has been the only reliable method for imaging the biliary tree, but it is invasive and carries a risk of complications. Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive method for imaging the biliary tree. The aim of this study was to prospectively assess the accuracy of MRCP in a large number of patients. METHODS: Consecutive patients referred to a teaching hospital for ERCP were eligible for study entry. MRCP was performed within 24 hours before ERCP. MRCP findings were compared with ERCP findings or, when the initial ERCP was unsuccessful, with results of repeat ERCP, percutaneous transhepatic cholangiography, or surgery. RESULTS: One hundred forty-six patients underwent 149 ERCP/MRCP procedures, of which 129 were evaluable with successful MRCP and ERCP or an ERCP-equivalent study. Diagnoses included choledocholithiasis in 46 and biliary stricture in 12 patients. The sensitivity, specificity, positive, and negative predictive values for MRCP in the diagnosis of choledocholithiasis were 97.9%, 89.0%, 83.6%, and 98.6%, respectively. All 12 strictures were diagnosed by MRCP (sensitivity 100%, specificity 99.1%). CONCLUSIONS: MRCP is an accurate, noninvasive alternative to ERCP for imaging the biliary tree. Choledocholithiasis and biliary strictures can be reliably diagnosed or excluded by MRCP. MRCP should be used increasingly in patients with suspected biliary obstruction to select those who require a therapeutic procedure.     

经内镜细胞刷检查对胆管恶性狭窄性病变的诊断价值

目的 探讨经内镜细胞刷检查对胆管恶性狭窄性病变的诊断价值,分析影响诊断的因素.方法 对ERCP检查发现可疑胆管恶性狭窄的144例患者行胆管细胞刷检查.2004年-2006年在胆管内来回拉刷10次 2007年-2009年在狭窄部位来回拉刷20次,并重复操作2次.专业病理医师固定阅片,对照术后病理诊断和（或）临床最终诊断,分析细胞刷检查诊断胆管狭窄病变的作用.结果 最终诊断96例为胆管恶性狭窄,48例良性狭窄.恶性狭窄患者中78例细胞刷检查阳性（敏感度81.3%）,18例阴性 良性狭窄患者细胞刷检查均为阴性（特异度100.0%） 总体准确率87.5%.2007年-2009年间恶性狭窄性病变细胞刷检出率为87.7%（50/57）,2004年-2006年间检出率仅为71.8%（28/39）,差异有统计学意义（P＜0.05）.细胞刷检查阳性率与肿瘤来源及狭窄部位无明显关系.术后发生4例轻度胰腺炎、3例胆管炎、2例胆管出血,无严重并发症发生.结论 胆管细胞刷检查对恶性胆管狭窄病变具有较高的特异度和敏感度,于狭窄部位反复拉刷和重复操作有助于提高细胞刷检阳性率.     

Magnetic resonance cholangiopancreatography: evaluation in 150 patients.

BACKGROUND AND AIMS: Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive imaging technique for evaluating the biliary and pancreatic ducts. MRCP has reached a level of resolution and reliability where it may replace diagnostic endoscopic retrograde cholangio-pancreatography (ERCP). We analyzed the results of MRCP in adult patients with biliary or pancreatic disease, and compared the findings with those at surgery or on ERCP. METHODS: Data of 150 patients who underwent MRCP with both single slab and multislice rapid acquisition with relaxation enhancement sequences with half-fourier acquisition single-shot turbo spin echo techniques were analyzed. Patients were divided into four groups according to reason for referral for MRCP: obstructive jaundice (n = 65), chronic/acute pancreatitis (n = 25), screening prior to laparoscopic cholecystectomy (n = 20), and failed ERCP (n = 40). RESULTS: MRCP could accurately identify the level of biliary obstruction in 58 of 61 patients. Characterization of benign or malignant nature of a stricture was possible in 30 of 32 patients when findings of both MRCP and magnetic resonance imaging were analyzed together. MRCP revealed the morphology of the entire pancreatic duct in 13 of 15 patients having ductal changes on endoscopic retrograde pancreatography. CONCLUSION: MRCP has high sensitivity and specificity for detection of biliary dilatation, calculi, strictures and anatomical variants.     

A prospective comparison of the diagnostic accuracy of ERCP,MRCP, CT,and EUS in biliary strictures

BACKGROUND: The differential diagnosis of biliary strictures remains a challenge. This study evaluated magnetic resonance cholangiopancreatography (MRCP) as a new procedure in comparison with the established methods of diagnosis including ERCP or percutaneous transhepatic cholangiography (PTC), CT, and EUS. METHODS: Fifty patients (21 men, 29 women, mean age 65.7 years) with jaundice but no pain suspected to have biliary strictures were enrolled in this prospective study. MRCP, ERCP/PTC, CT, and EUS were performed prospectively; images and videotapes (EUS) of these tests were reviewed blindly under standardized conditions. Reference standards for comparison were surgery, a biopsy confirming malignancy, or the clinical course during follow-up (at least 12 months) in cases without histopathologic proof of malignancy. RESULTS: Seven patients ultimately proved to have jaundice caused by parenchymal liver disease and 43 had a biliary stricture (17 benign, 26 malignant). Forty patients underwent all 4 imaging tests. There were 10 patients in whom patient-specific problems precluded some procedures but who were included in an intention-to-diagnose analysis. The sensitivity and specificity for diagnosis of malignancy in the 50 patients were as follows: 85% / 75% for ERCP/PTC, 85% / 71% for MRCP, 77% / 63% for CT, and 79% / 62% for EUS, with similar values in the 40 patients who underwent all 4 imaging methods. The combination of MRCP and EUS improved specificity. CONCLUSIONS: Although MRCP provides the same imaging information as direct cholangiography, it has limited specificity for the diagnosis of malignant strictures. In the differential diagnosis of biliary strictures, several tests including ERCP-guided tissue diagnosis are still required, and MRCP has only a limited clinical role.     

Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis

OBJECTIVE: Endoscopic retrograde cholangiopancreatography (ERCP) has become established as the gold standard in imaging of the biliary tree. Recently, magnetic resonance cholangiopancreatography (MRCP) has been introduced as a new, non-invasive imaging modality for the detection of bile-duct stones and other pathology related to the biliary tract and pancreas. The aim of this study was to determine how MRCP compared with ERCP in the diagnosis of choledocholithiasis. DESIGN AND METHODS: A prospective study of 133 patients referred for either ERCP or MRCP was carried out to compare the results of both these methods in determining the presence of choledocholithiasis. RESULTS: 18 patients were excluded from the analysis: ERCP was unsuccessful in eight of these patients and MRCP was not possible in the remaining 10 patients. There were six false negative results with MRCP; in five of these the calculi were less than 5 mm in diameter. MRCP showed a sensitivity of 84%, specificity of 96%, positive predictive value of 91%, negative predictive value of 93% and diagnostic accuracy of 92% when compared to ERCP as the gold standard. CONCLUSIONS: MRCP has high sensitivity and high specificity for stones greater than 5 mm in diameter and should be performed in preference to ERCP as the first-line investigation in patients with gallstones and abnormal liver function tests in the elective setting. Adoption of this guideline at our institution would result in a 9% reduction in the number of ERCPs performed.     

核磁共振胰胆管造影与内镜下逆行胰胆管造影在胰胆疾病诊断方面的对比研究

目的：探索核磁共振胰胆管造影（ＭＲＣＰ）检查在临床应用中的价值。方法：对１１０例胰胆管疾病患者选择性地行ＭＲＣＰ检查,并与内镜下逆行胰胆管造影（ＥＲＣＰ）检查作比较,结合内镜下治疗以及外科手术,以明确两者之间的相关性。ＥＲＣＰ和手术结果作为金标准。结果：１１０例患者ＭＲＣＰ图像质量均较高,对胆管扩张诊断的敏感性为８５．０６％（７８／８７）,对胆管下段狭窄伴扩张诊断的敏感性为９０％（１８／２０）。Ｍ     

Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis

OBJECTIVES: ERCP is the gold standard for pancreaticobiliary evaluation but is associated with complications. Less invasive diagnostic alternatives with similar capabilities may be cost-effective, particularly in situations involving low prevalence of disease. The aim of this study was to compare the performance of endoscopic ultrasound (EUS) with magnetic resonance cholangiopancreatography (MRCP) and ERCP in the same patients with suspected extrahepatic biliary disease. The economic outcomes of EUS-, MRCP-, and ERCP-based diagnostic strategies were evaluated. METHODS: Prospective cohort study of patients referred for ERCP with suspected biliary disease. MRCP and EUS were performed within 24 h before ERCP. The investigators were blinded to the results of the alternative imaging studies. A cost-utility analysis was performed for initial ERCP, MRCP, and EUS strategies for these patients. RESULTS: A total of 30 patients were studied. ERCP cholangiogram failed in one patient, and another patient did not complete MRCP because of claustrophobia. The final diagnoses (N = 28) were CBD stone (mean = 4 mm; range = 3-6 mm) in five patients; biliary stricture in three patients, and normal biliary tree in 20. Two patients had pancreatitis after therapeutic ERCP, one after precut sphincterotomy followed by a normal cholangiogram. EUS was more sensitive than MRCP in the detection of choledocolithiasis (80% vs 40%), with similar specificity. MRCP had a poor specificity and positive predictive value for the diagnosis of biliary stricture (76%/25%) compared to EUS (100%/100%), with similar sensitivity. The overall accuracy of MRCP for any abnormality was 61% (95% CI = 0.41-0.78) compared to 89% (CI = 0.72-0.98) for EUS. Among those patients with a normal biliary tree, the proportion correctly identified with each test was 95% for EUS and 65% for MRCP (p < 0.02). The cost for each strategy per patient evaluated was $1346 for ERCP, $1111 for EUS, and $1145 for MRCP. CONCLUSIONS: In this patient population with a low disease prevalence, EUS was superior to MRCP for choledocholithiasis. EUS was most useful for confirming a normal biliary tree and should be considered a low-risk alternative to ERCP. Although MRCP had the lowest procedural reimbursement, the initial EUS strategy had the greatest cost-utility by avoiding unnecessary ERCP examinations.